Turning microgravity opportunities into sustainable industrial projects.
Microgravity offers unique competitive advantages: more predictive biological models, orderly three-dimensional cell growth, and the absence of convection or sedimentation. However, to transform these discoveries into an industrial reality, a clear economic strategy is required. This macro-category explores innovative business models and investment pathways for the orbital biotech sector. Our objective is to connect terrestrial pharmaceutical companies with orbital biotech actors, reducing risks and accelerating innovation cycles to address unmet medical needs.